Next Article in Journal
Expression Profiling of the Transient Receptor Potential Vanilloid (TRPV) Channels 1, 2, 3 and 4 in Mucosal Epithelium of Human Ulcerative Colitis
Next Article in Special Issue
Tracking Cell Recruitment and Behavior within the Tumor Microenvironment Using Advanced Intravital Imaging Approaches
Previous Article in Journal
Unconventional Secretion and Intercellular Transfer of Mutant Huntingtin
Previous Article in Special Issue
A Caspase-3 Reporter for Fluorescence Lifetime Imaging of Single-Cell Apoptosis
Open AccessFeature PaperReview

Real-Time Imaging of Retinal Ganglion Cell Apoptosis

The Western Eye Hospital, Imperial College Healthcare NHS Trust (ICHNT), London NW1 5QH, UK
The Imperial College Ophthalmic Research Group (ICORG), Imperial College London, London NW1 5QH, UK
Glaucoma and Retinal Neurodegeneration Group, Department of Visual Neuroscience, UCL Institute of Ophthalmology, London EC1V 9EL, UK
Author to whom correspondence should be addressed.
Cells 2018, 7(6), 60;
Received: 9 May 2018 / Revised: 6 June 2018 / Accepted: 14 June 2018 / Published: 15 June 2018
(This article belongs to the Special Issue Innovative Methods to Monitor Single Live Cells)
Monitoring real-time apoptosis in-vivo is an unmet need of neurodegeneration science, both in clinical and research settings. For patients, earlier diagnosis before the onset of symptoms provides a window of time in which to instigate treatment. For researchers, being able to objectively monitor the rates of underlying degenerative processes at a cellular level provides a biomarker with which to test novel therapeutics. The DARC (Detection of Apoptosing Retinal Cells) project has developed a minimally invasive method using fluorescent annexin A5 to detect rates of apoptosis in retinal ganglion cells, the key pathological process in glaucoma. Numerous animal studies have used DARC to show efficacy of novel, pressure-independent treatment strategies in models of glaucoma and other conditions where retinal apoptosis is reported, including Alzheimer’s disease. This may forge exciting new links in the clinical science of treating both cognitive and visual decline. Human trials are now underway, successfully demonstrating the safety and efficacy of the technique to differentiate patients with progressive neurodegeneration from healthy individuals. We review the current perspectives on retinal ganglion cell apoptosis, the way in which this can be imaged, and the exciting advantages that these future methods hold in store. View Full-Text
Keywords: retinal ganglion cell; apoptosis; neurodegeneration; glaucoma; annexin; imaging retinal ganglion cell; apoptosis; neurodegeneration; glaucoma; annexin; imaging
Show Figures

Figure 1

MDPI and ACS Style

Yap, T.E.; Donna, P.; Almonte, M.T.; Cordeiro, M.F. Real-Time Imaging of Retinal Ganglion Cell Apoptosis. Cells 2018, 7, 60.

AMA Style

Yap TE, Donna P, Almonte MT, Cordeiro MF. Real-Time Imaging of Retinal Ganglion Cell Apoptosis. Cells. 2018; 7(6):60.

Chicago/Turabian Style

Yap, Timothy E.; Donna, Piero; Almonte, Melanie T.; Cordeiro, Maria F. 2018. "Real-Time Imaging of Retinal Ganglion Cell Apoptosis" Cells 7, no. 6: 60.

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Search more from Scilit
Back to TopTop